{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:06:05Z","timestamp":1744178765477},"reference-count":32,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.vaccine.2010.12.132","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T15:14:12Z","timestamp":1297782852000},"page":"2672-2678","source":"Crossref","is-referenced-by-count":17,"title":["Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1"],"prefix":"10.1016","volume":"29","author":[{"given":"Wen","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenci","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.132_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.olq.0000154512.86651.07","article-title":"Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study","volume":"32","author":"Andersen","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"May (4)","key":"10.1016\/j.vaccine.2010.12.132_bib0010","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/01443610500118749","article-title":"Incidence of genital Chlamydia trachomatis infection in the male partners attending an infertility clinic","volume":"25","author":"Arya","year":"2005","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2010.12.132_bib0015","article-title":"Chlamydia trachomatis evokes a relative anti-inflammatory response in a free Ca2+ dependent manner in human macrophages","author":"Azenabor","year":"2009","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.132_bib0020","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00007435-200106000-00008","article-title":"Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions","volume":"28","author":"Kilmarx","year":"2001","journal-title":"Sex Transm Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.132_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<35::AID-IJC6>3.0.CO;2-A","article-title":"Chlamydia trachomatis infection as a risk factor for invasive cervical cancer","volume":"85","author":"Koskela","year":"2000","journal-title":"Int J Cancer"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2010.12.132_bib0030","doi-asserted-by":"crossref","first-page":"10085","DOI":"10.1128\/JVI.01088-09","article-title":"Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines","volume":"83","author":"Schellenbacher","year":"2009","journal-title":"J Virol"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2010.12.132_bib0035","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2006.06.080","article-title":"HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice","volume":"25","author":"Berg","year":"2007","journal-title":"Vaccine"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2010.12.132_bib0040","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1007\/s00705-006-0798-8","article-title":"Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes","volume":"151","author":"Xu","year":"2006","journal-title":"Arch Virol"},{"issue":"November (10)","key":"10.1016\/j.vaccine.2010.12.132_bib0045","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.4049\/jimmunol.157.10.4554","article-title":"Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans","volume":"157","author":"Ortiz","year":"1996","journal-title":"J Immunol"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2010.12.132_bib0050","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.4049\/jimmunol.162.11.6855","article-title":"Induction of HLA class I-restricted CD8+ CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections","volume":"162","author":"Kim","year":"1999","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.132_bib0055","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/IAI.64.2.542-547.1996","article-title":"The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope","volume":"64","author":"Batteiger","year":"1996","journal-title":"Infect Immun"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0060","first-page":"232","article-title":"Immunogenicity of multi-epitopes gene of major outer membrane protein of Chlamydia trachomatis","volume":"43","author":"Zhu","year":"2009","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.132_bib0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1365-2249.1997.2511129.x","article-title":"Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population","volume":"107","author":"Holland","year":"1997","journal-title":"Clin Exp Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2010.12.132_bib0070","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1128\/IAI.63.9.3527-3530.1995","article-title":"Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars","volume":"63","author":"Starnbach","year":"1995","journal-title":"Infect Immun"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2010.12.132_bib0075","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2010.12.132_bib0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7883\/yoken.JJID.2007.347","article-title":"Kinetic study of antibodies (IgG, IgA) to Chlamydia trachomatis: importance of IgA antibody in screening test for C. trachomatis infection by peptide-based enzyme immunosorbent assay","volume":"60","author":"Komoda","year":"2007","journal-title":"Jpn J Infect Dis"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2010.12.132_bib0085","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.173.5.3375","article-title":"A novel recombinant multisubunit vaccine against Chlamydia","volume":"173","author":"Eko","year":"2004","journal-title":"J Immunol"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2010.12.132_bib0090","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/IAI.68.6.3074-3078.2000","article-title":"Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses","volume":"68","author":"Dong-Ji","year":"2000","journal-title":"Infect Immun"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2010.12.132_bib0095","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/516545","article-title":"DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection","volume":"176","author":"Zhang","year":"1997","journal-title":"J Infect Dis"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2010.12.132_bib0100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.pep.2008.01.021","article-title":"Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae","volume":"59","author":"Park","year":"2008","journal-title":"Protein Expr Purif"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2010.12.132_bib0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1006\/viro.1997.8912","article-title":"Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway","volume":"240","author":"Peng","year":"1998","journal-title":"Virology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ygyno.2004.10.040","article-title":"Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles","volume":"96","author":"Bontkes","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.132_bib0115","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/eji.200425547","article-title":"Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells","volume":"35","author":"Lenz","year":"2005","journal-title":"Eur J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1521-6616(02)00039-6","article-title":"Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells","volume":"106","author":"Lenz","year":"2003","journal-title":"Clin Immunol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2010.12.132_bib0125","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/intimm\/13.5.633","article-title":"Physical interaction of human papillomavirus virus-like particles with immune cells","volume":"13","author":"Da Silva","year":"2001","journal-title":"Int Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0130","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/IAI.74.3.1795-1799.2006","article-title":"Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans","volume":"74","author":"Stephens","year":"2006","journal-title":"Infect Immun"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2010.12.132_bib0135","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1128\/JVI.75.9.4150-4157.2001","article-title":"Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation","volume":"75","author":"Payne","year":"2001","journal-title":"J Virol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0140","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1128\/JVI.71.3.2449-2456.1997","article-title":"Identification of the alpha6 integrin as a candidate receptor for papillomaviruses","volume":"71","author":"Evander","year":"1997","journal-title":"J Virol"},{"issue":"December (11)","key":"10.1016\/j.vaccine.2010.12.132_bib0145","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.4049\/jimmunol.169.11.6324","article-title":"GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis","volume":"169","author":"Lu","year":"2002","journal-title":"J Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2010.12.132_bib0150","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/IAI.72.2.1019-1028.2004","article-title":"Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection","volume":"72","author":"Berry","year":"2004","journal-title":"Infect Immun"},{"issue":"May-Jun (3)","key":"10.1016\/j.vaccine.2010.12.132_bib0155","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4161\/hv.4.3.5393","article-title":"Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness","volume":"4","author":"Eko","year":"2008","journal-title":"Hum Vaccin"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2010.12.132_bib0160","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/IAI.68.12.6798-6806.2000","article-title":"Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes","volume":"68","author":"Igietseme","year":"2000","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11000132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:11:19Z","timestamp":1712203879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11000132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":32,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0264410X11000132"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.132","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}